# CMO Letter to Reduce Inappropriate Antibiotic Prescribing Winter 2019/2020

> **NCT04051281** · NA · COMPLETED · sponsor: **Public Health England** · enrollment: 2963 (actual)

## Conditions studied

- Prescribing, Off-Label

## Interventions

- **BEHAVIORAL:** Letter

## Key facts

- **NCT ID:** NCT04051281
- **Lead sponsor:** Public Health England
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-08-31
- **Primary completion:** 2020-08-30
- **Final completion:** 2020-08-30
- **Target enrollment:** 2963 (ACTUAL)
- **Last updated:** 2020-09-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04051281

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04051281, "CMO Letter to Reduce Inappropriate Antibiotic Prescribing Winter 2019/2020". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04051281. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*